C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
150/11, 150/14
C12Q 1/46 (2006.01) A61K 38/24 (2006.01) A61K 38/27 (2006.01) A61K 45/06 (2006.01) G01N 33/50 (2006.01) G01N 33/74 (2006.01)
Patent
CA 1323294
ABSTRACT OF THE DISCLOSURE A method of treating humans suffering from central nervous system diseases, such as Alzheimer's disease, cerebral atrophy, Parkinson's disease, senile dementia, senile tremor, essential tremor, multiple schlerosis, cerebovascular accidents, and cerebellar atrophy, as well as diseases where dementia is present. The treatment consists of inducing into the patient's blood stream at least one from the group consisting of: sex hormones and anabolic hormones. (HGH, NCG, trophobostic hormone). Ergolid myselates, dopamine, cathecoline, serotonin, amphetamine may be used in conjunction with the hormone, as well as a vasodilator and non-steroid anti-inflammatory. Growth hormone may also be used in those patients in advanced stages of the disease, or in those patients where it has been determined that a low level o growth hormone is present, clinical deterioration not having been corrected by other hormones. A method of diagnosing Alzheimer's disease, senile dementia, by the determination of the levels of the hormones somatotropin (human growth hormone) and somatomedin-C (IGF-I) after the administration of the Aroonsakul-Allen provocative test. Blood-sera samples are taken every thirty minutes for a two hour period after the administration of L-Dopa, and the samples are tested for the levels of these hormones. These levels are then compared against the levels for normal subjects in the age group of between fifty years and sixty years. If the levels of the patient being diagnosed falls below the statistical mean corrected for error, then a diagnosis of Alzheimer's disease is indicated what is equivalent to severe HGH deficiency, mild and moderate, HGH deficiency indicating senile dementia in early and late stage. 36
555899
Aroonsakul Chaovanee
Smart & Biggar
LandOfFree
Method of treatment of central nervous system diseases such... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment of central nervous system diseases such..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of central nervous system diseases such... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1259655